These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23634669)

  • 1. Has the time come for routine imaging studies in diabetes?
    Mohan V
    Diabetes Technol Ther; 2013 May; 15(5):349-50. PubMed ID: 23634669
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity and diabetes: newer concepts in imaging.
    Garg K; Chang S; Scherzinger A
    Diabetes Technol Ther; 2013 May; 15(5):351-61. PubMed ID: 23634670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 4. Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.
    Polyzos SA; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):161-7. PubMed ID: 24290839
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential of electron beam computed tomography for coronary artery calcium screening to evaluate fatty liver: comparison with 1H magnetic resonance spectroscopy in the Dallas Heart Study.
    Matulevicius S; Huff LC; Szczepaniak LS; Ayers CR; Budoff M; McColl R; Khera A; Peshock RM
    J Investig Med; 2011 Jun; 59(5):780-6. PubMed ID: 21441828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].
    Kim MY; Baik SK
    Korean J Hepatol; 2008 Mar; 14(1):1-3. PubMed ID: 18367852
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical consequences of obesity.
    Lawrence VJ; Kopelman PG
    Clin Dermatol; 2004; 22(4):296-302. PubMed ID: 15475229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.
    Della Pepa G; Vetrani C; Lombardi G; Bozzetto L; Annuzzi G; Rivellese AA
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.
    van Werven JR; Schreuder TC; Nederveen AJ; Lavini C; Jansen PL; Stoker J
    Eur J Radiol; 2010 Aug; 75(2):e102-7. PubMed ID: 20116951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
    Kieć-Wilk B; Klupa T; Dembińska-Kieć A
    Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.
    Arrese M
    Nat Rev Endocrinol; 2010 Dec; 6(12):660-1. PubMed ID: 21102646
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
    Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
    Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
    Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic.
    Ahmed MH; Osman MM
    Br J Hosp Med (Lond); 2006 May; 67(5):267. PubMed ID: 16729640
    [No Abstract]   [Full Text] [Related]  

  • 17. Focal fatty infiltration of the liver: demonstration by magnetic resonance imaging.
    Wenker JC; Baker MK; Ellis JH; Glant MD
    AJR Am J Roentgenol; 1984 Sep; 143(3):573-4. PubMed ID: 6331737
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.